The restaurant is closing after 27 years in Columbus.

With little public explanation, the chain has slowly contracted over the years and now operates a fraction of its former ...

BD's outgoing diagnostic solutions and biosciences catalog brought in about $3.4 billion in 2024 sales. It will include tests for infectious disease and cervical cancer screening, as well as flow ...

Global medtech giant BD announced that it is adding capacity to its US-based footprint for the production of critical medical devices, including syringes, needles, and IV catheters. As part of the ...

Waters and BD shareholders are set to split ownership of the new outfit at about 60-40, respectively, while BD will also receive about $4 billion in cash. (Getty Images) BD has found a new home for ...

BD (BDX), the MedTech firm also known as Becton, Dickinson, traded lower in the premarket on Monday despite posting better-than-expected financials for Q1 fiscal 2026, as its life sciences segment ...

On February 5, 2025, Becton, Dickinson and Company (BD) announced plans to separate its Biosciences and Diagnostic Solutions business into an independent entity. The Biosciences and Diagnostic ...